Mariacarmela Allocca

Title: Mariacarmela Allocca: Innovator in Genetic Treatments

Introduction

Mariacarmela Allocca is a prominent inventor based in Cambridge, MA, specializing in genetic treatments for rare diseases. She has made significant contributions to the field of medicine, particularly in the treatment of Usher Syndrome Type 2A and non-syndromic autosomal recessive retinitis pigmentosa (ARRP). With a total of 2 patents, her work is paving the way for innovative therapeutic solutions.

Latest Patents

Allocca's latest patents focus on materials and methods for treating patients with Usher Syndrome Type 2A and ARRP. These patents provide comprehensive approaches for editing the USH2A gene, specifically targeting a guanine deletion at nucleotide position c.2299. The applications include both ex vivo and in vivo treatments, offering a range of therapeutic options, including gRNAs and sgRNAs for gene editing. Additionally, her patents outline the development of kits designed for effective treatment of these conditions.

Career Highlights

Throughout her career, Allocca has worked with leading companies in the biotechnology sector, including Crispr Therapeutics AG and Bayer Healthcare LLC. Her experience in these organizations has allowed her to collaborate with some of the brightest minds in the field, further enhancing her innovative capabilities.

Collaborations

Allocca has collaborated with notable colleagues such as Akiko Noma and Abraham Scaria, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Mariacarmela Allocca's contributions to genetic treatments exemplify her dedication to advancing medical science. Her innovative patents and collaborations position her as a key figure in the ongoing fight against genetic disorders.